silybin has been researched along with rhodamine 123 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, JS; Choi, SJ; Kim, CS; Li, C; Park, CY | 1 |
| Choi, JS; Lee, MY; Li, C | 1 |
2 other study(ies) available for silybin and rhodamine 123
| Article | Year |
|---|---|
Effects of silybinin on the pharmacokinetics of tamoxifen and its active metabolite, 4-hydroxytamoxifen in rats.
Topics: Animals; Antioxidants; Aryl Hydrocarbon Hydroxylases; Biological Availability; Cell Line, Tumor; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Humans; Male; Rats; Rats, Sprague-Dawley; Rhodamine 123; Silybin; Silymarin; Tamoxifen | 2010 |
Effects of silybinin, CYP3A4 and P-glycoprotein inhibitor in vitro, on the bioavailability of loratadine in rats.
Topics: Administration, Oral; Animals; Antioxidants; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Fluorescent Dyes; Half-Life; Histamine H1 Antagonists, Non-Sedating; Injections, Intravenous; Loratadine; Male; Rats; Rats, Sprague-Dawley; Rhodamine 123; Silybin; Silymarin | 2010 |